Doerte is a pharmacist by education and joined Bayer AG more than 15 years ago (at that time Schering AG), where she held various positions within the Regulatory Affairs organization, such as Regulatory Affairs Manager responsible for the Region Asia Pacific and China, Global Regulatory Strategist being responsible for products in the Specialty Medicines and Dermatology area. She also has been working as Operational Manager supporting the Regulatory Affairs Head and Leadership team. Doerte is now part of the Regulatory Policy & Intelligence team being based in Basel, Switzerland. She is a member of the EU-Regulatory Intelligence Network Group as well as a member of the EFPIA ERAO working group on Scientific Dialogue.

Pharmacist by training, Bertrand started his career as a regulatory professional in the bio-pharma industry more than 20 years ago. He held various positions in national, regional and global RA departments, in several companies such as 3M Pharmaceuticals, Baxter and Janssen. He gathered comprehensive experience in the areas of drug development, clinical trials and pre-approval interactions with Health Authorities as well as a strong knowledge base of the of the EU and global regulatory landscape. Since 2019, Bertrand is leading the Regulatory Policy & Intelligence function at Shionogi Europe. He is representing his company at the EU Trade Association EUCOPE where he is co-leading the Clinical Trial Focus Group.

Kasia is chemist by training and has have been working in the pharmaceutical industry since 2006 in generic and a research-based biopharmaceutical sectors, in various human regulatory affairs roles, predominantly in post-marketing authorisation (from affiliate and HQ perspective), drug development and since 2018 in Regulatory Intelligence and Policy at UCB. Kasia is representing UCB at various Trade Associations (BIA, ABPI, EFPIA ERAO working groups) and is currently Co-Chair of the EU Regulatory Intelligence Networking Group (EU RING).

Iain has an educational background in both law and science and holds a Master's degree in Pharmaceutical Medicine. He started his career at Pfizer before joining GSK in 2011, where he is now a member of the Regulatory Policy and Intelligence team. Iain is currently Co-Chair of the EU Regulatory Intelligence Networking Group (EU RING).